Followers | 1073 |
Posts | 89969 |
Boards Moderated | 8 |
Alias Born | 07/26/2007 |
Wednesday, October 19, 2016 12:35:03 PM
http://ih.advfn.com/p.php?pid=nmona&article=72699300&symbol=TNXP
GlobeNewswire• October 19, 2016
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix), which is developing a next-generation treatment for PTSD, announced today that it will host an educational event featuring prominent academic physicians to review issues related to understanding and treating PTSD on October 26, 2016 in New York, NY.
This PTSD Awareness Day will feature presentations by Jonathan R.T. Davidson, M.D., professor of Psychiatry and Behavioral Sciences and former Director of the Anxiety and Traumatic Stress Program at Duke University Medical Center, and Thomas A. Mellman, M.D., Professor of Psychiatry and the Director of the Center for Clinical & Translational Science and the Sleep Stress Program at Howard University Medical Center. In addition, Tonix’s president and chief executive officer, Seth Lederman M.D., and chief medical officer, Gregory Sullivan, M.D., will provide a corporate update and review of Tonix’s PTSD clinical program.
Tonix recently held a successful end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) based on positive data from its randomized, double-blind, placebo-controlled Phase 2 AtEase clinical trial evaluating TNX-102 SL (cyclobenzaprine HCl sublingual tablets) in military-related PTSD.
TNXP has nice news again for today! It is the cheapest Bio-Tech NASDAQ stock! Easy Quick double from the current ridiculous low price levels...
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11597285
OTC-Killers-Club has spot 349 stock killers from 9000-Bagger to 2.2-bagger since 03/05/2011
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:05:27 PM
- Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 12:05:48 PM
- Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:10:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:10:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:07:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:05:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 09:16:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 12:05:37 PM
- Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting • GlobeNewswire Inc. • 05/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 12:07:07 PM
- Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase • GlobeNewswire Inc. • 05/15/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:56:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:51:45 PM
- Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 05/13/2024 08:30:00 PM
- Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights • GlobeNewswire Inc. • 04/01/2024 08:15:00 PM
- Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering • GlobeNewswire Inc. • 03/28/2024 01:32:56 PM
- Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM